CN114181321B - 花鲈fgf6a、fgf6b以及fgf18重组蛋白及其制备方法和应用 - Google Patents
花鲈fgf6a、fgf6b以及fgf18重组蛋白及其制备方法和应用 Download PDFInfo
- Publication number
- CN114181321B CN114181321B CN202111505223.XA CN202111505223A CN114181321B CN 114181321 B CN114181321 B CN 114181321B CN 202111505223 A CN202111505223 A CN 202111505223A CN 114181321 B CN114181321 B CN 114181321B
- Authority
- CN
- China
- Prior art keywords
- fgf6b
- fgf6a
- fgf18
- seq
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101000878128 Homo sapiens Fibroblast growth factor 18 Proteins 0.000 title claims abstract description 72
- 102100035323 Fibroblast growth factor 18 Human genes 0.000 title claims abstract description 70
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title claims abstract description 53
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title claims abstract description 53
- 241000269795 Lateolabrax japonicus Species 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 33
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 21
- 241000894006 Bacteria Species 0.000 claims abstract description 16
- DLZKEQQWXODGGZ-KCJUWKMLSA-N 2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DLZKEQQWXODGGZ-KCJUWKMLSA-N 0.000 claims abstract description 10
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 6
- 150000001413 amino acids Chemical class 0.000 claims description 20
- 239000013604 expression vector Substances 0.000 claims description 13
- 239000013612 plasmid Substances 0.000 claims description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 101800001117 Ubiquitin-related Proteins 0.000 claims description 3
- 102000035118 modified proteins Human genes 0.000 claims description 3
- 108091005573 modified proteins Proteins 0.000 claims description 3
- 108010093488 His-His-His-His-His-His Proteins 0.000 claims description 2
- 238000001042 affinity chromatography Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 241000353340 Helicolenus percoides Species 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 230000003381 solubilizing effect Effects 0.000 claims 1
- 230000014509 gene expression Effects 0.000 abstract description 10
- 239000013598 vector Substances 0.000 abstract description 6
- 238000009395 breeding Methods 0.000 abstract description 5
- 230000001488 breeding effect Effects 0.000 abstract description 5
- 230000006698 induction Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 9
- 241000251468 Actinopterygii Species 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000002363 skeletal muscle cell Anatomy 0.000 description 7
- 241000269799 Perca fluviatilis Species 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 5
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 5
- 108010068380 arginylarginine Proteins 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- MCKSLROAGSDNFC-ACZMJKKPSA-N Ala-Asp-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MCKSLROAGSDNFC-ACZMJKKPSA-N 0.000 description 4
- CHFFHQUVXHEGBY-GARJFASQSA-N Ala-Lys-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N CHFFHQUVXHEGBY-GARJFASQSA-N 0.000 description 4
- MZRBYBIQTIKERR-GUBZILKMSA-N Arg-Glu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MZRBYBIQTIKERR-GUBZILKMSA-N 0.000 description 4
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 4
- 101150021185 FGF gene Proteins 0.000 description 4
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 4
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 4
- BPDVTFBJZNBHEU-HGNGGELXSA-N Glu-Ala-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 BPDVTFBJZNBHEU-HGNGGELXSA-N 0.000 description 4
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 4
- LZHJZLHSRGWBBE-IHRRRGAJSA-N Leu-Lys-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LZHJZLHSRGWBBE-IHRRRGAJSA-N 0.000 description 4
- WFCKERTZVCQXKH-KBPBESRZSA-N Leu-Tyr-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O WFCKERTZVCQXKH-KBPBESRZSA-N 0.000 description 4
- GAOJCVKPIGHTGO-UWVGGRQHSA-N Lys-Arg-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O GAOJCVKPIGHTGO-UWVGGRQHSA-N 0.000 description 4
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 4
- VQXAVLQBQJMENB-SRVKXCTJSA-N Lys-Glu-Met Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O VQXAVLQBQJMENB-SRVKXCTJSA-N 0.000 description 4
- BNFVPSRLHHPQKS-WHFBIAKZSA-N Ser-Asp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O BNFVPSRLHHPQKS-WHFBIAKZSA-N 0.000 description 4
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 4
- 230000009465 prokaryotic expression Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 4
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 3
- UGZUVYDKAYNCII-ULQDDVLXSA-N Arg-Phe-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UGZUVYDKAYNCII-ULQDDVLXSA-N 0.000 description 3
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 3
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 3
- BRRPVTUFESPTCP-ACZMJKKPSA-N Asp-Ser-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O BRRPVTUFESPTCP-ACZMJKKPSA-N 0.000 description 3
- MLCPTRRNICEKIS-FXQIFTODSA-N Glu-Asn-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MLCPTRRNICEKIS-FXQIFTODSA-N 0.000 description 3
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 3
- BZKDJRSZWLPJNI-SRVKXCTJSA-N His-His-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O BZKDJRSZWLPJNI-SRVKXCTJSA-N 0.000 description 3
- UROVZOUMHNXPLZ-AVGNSLFASA-N His-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 UROVZOUMHNXPLZ-AVGNSLFASA-N 0.000 description 3
- YVCGJPIKRMGNPA-LSJOCFKGSA-N His-Met-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O YVCGJPIKRMGNPA-LSJOCFKGSA-N 0.000 description 3
- ATXGFMOBVKSOMK-PEDHHIEDSA-N Ile-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N ATXGFMOBVKSOMK-PEDHHIEDSA-N 0.000 description 3
- CDGLBYSAZFIIJO-RCOVLWMOSA-N Ile-Gly-Gly Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O CDGLBYSAZFIIJO-RCOVLWMOSA-N 0.000 description 3
- ODPKZZLRDNXTJZ-WHOFXGATSA-N Ile-Gly-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N ODPKZZLRDNXTJZ-WHOFXGATSA-N 0.000 description 3
- CIDLJWVDMNDKPT-FIRPJDEBSA-N Ile-Phe-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N CIDLJWVDMNDKPT-FIRPJDEBSA-N 0.000 description 3
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 3
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 3
- 239000012880 LB liquid culture medium Substances 0.000 description 3
- 241000269794 Lateolabrax Species 0.000 description 3
- QOJDBRUCOXQSSK-AJNGGQMLSA-N Lys-Ile-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(O)=O QOJDBRUCOXQSSK-AJNGGQMLSA-N 0.000 description 3
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 3
- 101150094019 MYOG gene Proteins 0.000 description 3
- MTBVQFFQMXHCPC-CIUDSAMLSA-N Met-Glu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MTBVQFFQMXHCPC-CIUDSAMLSA-N 0.000 description 3
- LRALLISKBZNSKN-BQBZGAKWSA-N Met-Gly-Ser Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LRALLISKBZNSKN-BQBZGAKWSA-N 0.000 description 3
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 3
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 3
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 3
- IOVBCLGAJJXOHK-SRVKXCTJSA-N Ser-His-His Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IOVBCLGAJJXOHK-SRVKXCTJSA-N 0.000 description 3
- VIIJCAQMJBHSJH-FXQIFTODSA-N Ser-Met-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O VIIJCAQMJBHSJH-FXQIFTODSA-N 0.000 description 3
- GYDFRTRSSXOZCR-ACZMJKKPSA-N Ser-Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O GYDFRTRSSXOZCR-ACZMJKKPSA-N 0.000 description 3
- WBCCCPZIJIJTSD-TUBUOCAGSA-N Thr-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H]([C@@H](C)O)N WBCCCPZIJIJTSD-TUBUOCAGSA-N 0.000 description 3
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 3
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 3
- GXAZTLJYINLMJL-LAEOZQHASA-N Val-Asn-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N GXAZTLJYINLMJL-LAEOZQHASA-N 0.000 description 3
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 102000003977 fibroblast growth factor 18 Human genes 0.000 description 3
- 108090000370 fibroblast growth factor 18 Proteins 0.000 description 3
- 108010028295 histidylhistidine Proteins 0.000 description 3
- 108010092114 histidylphenylalanine Proteins 0.000 description 3
- 108010030617 leucyl-phenylalanyl-valine Proteins 0.000 description 3
- 108010057821 leucylproline Proteins 0.000 description 3
- 108010012058 leucyltyrosine Proteins 0.000 description 3
- 108010054155 lysyllysine Proteins 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 108010061238 threonyl-glycine Proteins 0.000 description 3
- 108010073969 valyllysine Proteins 0.000 description 3
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 2
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 2
- KLALXKYLOMZDQT-ZLUOBGJFSA-N Ala-Ser-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KLALXKYLOMZDQT-ZLUOBGJFSA-N 0.000 description 2
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 2
- BGGAIXWIZCIFSG-XDTLVQLUSA-N Ala-Tyr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O BGGAIXWIZCIFSG-XDTLVQLUSA-N 0.000 description 2
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 2
- YSUVMPICYVWRBX-VEVYYDQMSA-N Arg-Asp-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YSUVMPICYVWRBX-VEVYYDQMSA-N 0.000 description 2
- HQIZDMIGUJOSNI-IUCAKERBSA-N Arg-Gly-Arg Chemical compound N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQIZDMIGUJOSNI-IUCAKERBSA-N 0.000 description 2
- AUFHLLPVPSMEOG-YUMQZZPRSA-N Arg-Gly-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AUFHLLPVPSMEOG-YUMQZZPRSA-N 0.000 description 2
- ZATRYQNPUHGXCU-DTWKUNHWSA-N Arg-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ZATRYQNPUHGXCU-DTWKUNHWSA-N 0.000 description 2
- MMGCRPZQZWTZTA-IHRRRGAJSA-N Arg-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N MMGCRPZQZWTZTA-IHRRRGAJSA-N 0.000 description 2
- LXMKTIZAGIBQRX-HRCADAONSA-N Arg-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O LXMKTIZAGIBQRX-HRCADAONSA-N 0.000 description 2
- WKPXXXUSUHAXDE-SRVKXCTJSA-N Arg-Pro-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O WKPXXXUSUHAXDE-SRVKXCTJSA-N 0.000 description 2
- KXOPYFNQLVUOAQ-FXQIFTODSA-N Arg-Ser-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KXOPYFNQLVUOAQ-FXQIFTODSA-N 0.000 description 2
- INOIAEUXVVNJKA-XGEHTFHBSA-N Arg-Thr-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O INOIAEUXVVNJKA-XGEHTFHBSA-N 0.000 description 2
- FXGMURPOWCKNAZ-JYJNAYRXSA-N Arg-Val-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FXGMURPOWCKNAZ-JYJNAYRXSA-N 0.000 description 2
- AKEBUSZTMQLNIX-UWJYBYFXSA-N Asn-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N AKEBUSZTMQLNIX-UWJYBYFXSA-N 0.000 description 2
- GMRGSBAMMMVDGG-GUBZILKMSA-N Asn-Arg-Arg Chemical compound C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N GMRGSBAMMMVDGG-GUBZILKMSA-N 0.000 description 2
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 2
- PQAIOUVVZCOLJK-FXQIFTODSA-N Asn-Gln-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N PQAIOUVVZCOLJK-FXQIFTODSA-N 0.000 description 2
- RBOBTTLFPRSXKZ-BZSNNMDCSA-N Asn-Phe-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RBOBTTLFPRSXKZ-BZSNNMDCSA-N 0.000 description 2
- FHCRKXCTKSHNOE-QEJZJMRPSA-N Asn-Trp-Glu Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FHCRKXCTKSHNOE-QEJZJMRPSA-N 0.000 description 2
- RTFXPCYMDYBZNQ-SRVKXCTJSA-N Asn-Tyr-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O RTFXPCYMDYBZNQ-SRVKXCTJSA-N 0.000 description 2
- ZAESWDKAMDVHLL-RCOVLWMOSA-N Asn-Val-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O ZAESWDKAMDVHLL-RCOVLWMOSA-N 0.000 description 2
- PJERDVUTUDZPGX-ZKWXMUAHSA-N Asp-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(O)=O PJERDVUTUDZPGX-ZKWXMUAHSA-N 0.000 description 2
- YNCHFVRXEQFPBY-BQBZGAKWSA-N Asp-Gly-Arg Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N YNCHFVRXEQFPBY-BQBZGAKWSA-N 0.000 description 2
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 2
- NWAHPBGBDIFUFD-KKUMJFAQSA-N Asp-Tyr-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O NWAHPBGBDIFUFD-KKUMJFAQSA-N 0.000 description 2
- XQFLFQWOBXPMHW-NHCYSSNCSA-N Asp-Val-His Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O XQFLFQWOBXPMHW-NHCYSSNCSA-N 0.000 description 2
- NLDWTJBJFVWBDQ-KKUMJFAQSA-N Cys-Lys-Phe Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 NLDWTJBJFVWBDQ-KKUMJFAQSA-N 0.000 description 2
- 241000321429 Epinephelus itajara Species 0.000 description 2
- 108091008794 FGF receptors Proteins 0.000 description 2
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 2
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 2
- OCDLPQDYTJPWNG-YUMQZZPRSA-N Gly-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN OCDLPQDYTJPWNG-YUMQZZPRSA-N 0.000 description 2
- DGKBSGNCMCLDSL-BYULHYEWSA-N Gly-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN DGKBSGNCMCLDSL-BYULHYEWSA-N 0.000 description 2
- IUKIDFVOUHZRAK-QWRGUYRKSA-N Gly-Lys-His Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IUKIDFVOUHZRAK-QWRGUYRKSA-N 0.000 description 2
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 2
- WNZOCXUOGVYYBJ-CDMKHQONSA-N Gly-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CN)O WNZOCXUOGVYYBJ-CDMKHQONSA-N 0.000 description 2
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- PYNUBZSXKQKAHL-UWVGGRQHSA-N His-Gly-Arg Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O PYNUBZSXKQKAHL-UWVGGRQHSA-N 0.000 description 2
- UBHUJPVCJHPSEU-GRLWGSQLSA-N Ile-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N UBHUJPVCJHPSEU-GRLWGSQLSA-N 0.000 description 2
- YKZAMJXNJUWFIK-JBDRJPRFSA-N Ile-Ser-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)N YKZAMJXNJUWFIK-JBDRJPRFSA-N 0.000 description 2
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 2
- VFQOCUQGMUXTJR-DCAQKATOSA-N Leu-Cys-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)O)N VFQOCUQGMUXTJR-DCAQKATOSA-N 0.000 description 2
- CCQLQKZTXZBXTN-NHCYSSNCSA-N Leu-Gly-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CCQLQKZTXZBXTN-NHCYSSNCSA-N 0.000 description 2
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 2
- FYPWFNKQVVEELI-ULQDDVLXSA-N Leu-Phe-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 FYPWFNKQVVEELI-ULQDDVLXSA-N 0.000 description 2
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 2
- SXOFUVGLPHCPRQ-KKUMJFAQSA-N Leu-Tyr-Cys Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(O)=O SXOFUVGLPHCPRQ-KKUMJFAQSA-N 0.000 description 2
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 2
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 2
- VLMNBMFYRMGEMB-QWRGUYRKSA-N Lys-His-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 VLMNBMFYRMGEMB-QWRGUYRKSA-N 0.000 description 2
- JMNRXRPBHFGXQX-GUBZILKMSA-N Lys-Ser-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JMNRXRPBHFGXQX-GUBZILKMSA-N 0.000 description 2
- SUZVLFWOCKHWET-CQDKDKBSSA-N Lys-Tyr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O SUZVLFWOCKHWET-CQDKDKBSSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- CAODKDAPYGUMLK-FXQIFTODSA-N Met-Asn-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CAODKDAPYGUMLK-FXQIFTODSA-N 0.000 description 2
- XPVCDCMPKCERFT-GUBZILKMSA-N Met-Ser-Arg Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XPVCDCMPKCERFT-GUBZILKMSA-N 0.000 description 2
- ZBLSZPYQQRIHQU-RCWTZXSCSA-N Met-Thr-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ZBLSZPYQQRIHQU-RCWTZXSCSA-N 0.000 description 2
- 241001125889 Micropterus salmoides Species 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- 108010079364 N-glycylalanine Proteins 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- GNUCSNWOCQFMMC-UFYCRDLUSA-N Phe-Arg-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 GNUCSNWOCQFMMC-UFYCRDLUSA-N 0.000 description 2
- FXYXBEZMRACDDR-KKUMJFAQSA-N Phe-His-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O FXYXBEZMRACDDR-KKUMJFAQSA-N 0.000 description 2
- FUAIIFPQELBNJF-ULQDDVLXSA-N Phe-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N FUAIIFPQELBNJF-ULQDDVLXSA-N 0.000 description 2
- WEDZFLRYSIDIRX-IHRRRGAJSA-N Phe-Ser-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 WEDZFLRYSIDIRX-IHRRRGAJSA-N 0.000 description 2
- YUPRIZTWANWWHK-DZKIICNBSA-N Phe-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N YUPRIZTWANWWHK-DZKIICNBSA-N 0.000 description 2
- SGCZFWSQERRKBD-BQBZGAKWSA-N Pro-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 SGCZFWSQERRKBD-BQBZGAKWSA-N 0.000 description 2
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 2
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 2
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 2
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 2
- 108010025216 RVF peptide Proteins 0.000 description 2
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 2
- DKDHTRVDOUZZTP-IFFSRLJSSA-N Thr-Gln-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O DKDHTRVDOUZZTP-IFFSRLJSSA-N 0.000 description 2
- UDNVOQMPQBEITB-MEYUZBJRSA-N Thr-His-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O UDNVOQMPQBEITB-MEYUZBJRSA-N 0.000 description 2
- UDCHKDYNMRJYMI-QEJZJMRPSA-N Trp-Glu-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UDCHKDYNMRJYMI-QEJZJMRPSA-N 0.000 description 2
- SNJAPSVIPKUMCK-NWLDYVSISA-N Trp-Glu-Thr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SNJAPSVIPKUMCK-NWLDYVSISA-N 0.000 description 2
- SOEGLGLDSUHWTI-STECZYCISA-N Tyr-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=C(O)C=C1 SOEGLGLDSUHWTI-STECZYCISA-N 0.000 description 2
- BIWVVOHTKDLRMP-ULQDDVLXSA-N Tyr-Pro-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O BIWVVOHTKDLRMP-ULQDDVLXSA-N 0.000 description 2
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 2
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 2
- UZDHNIJRRTUKKC-DLOVCJGASA-N Val-Gln-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UZDHNIJRRTUKKC-DLOVCJGASA-N 0.000 description 2
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 2
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 2
- DOBHJKVVACOQTN-DZKIICNBSA-N Val-Tyr-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 DOBHJKVVACOQTN-DZKIICNBSA-N 0.000 description 2
- 238000001261 affinity purification Methods 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 108010080488 arginyl-arginyl-leucine Proteins 0.000 description 2
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 2
- 108010038633 aspartylglutamate Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 2
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 108010056582 methionylglutamic acid Proteins 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 108010072637 phenylalanyl-arginyl-phenylalanine Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- IVKWMMGFLAMMKJ-XVYDVKMFSA-N Ala-His-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N IVKWMMGFLAMMKJ-XVYDVKMFSA-N 0.000 description 1
- CBCCCLMNOBLBSC-XVYDVKMFSA-N Ala-His-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CBCCCLMNOBLBSC-XVYDVKMFSA-N 0.000 description 1
- RAAWHFXHAACDFT-FXQIFTODSA-N Ala-Met-Asn Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(O)=O RAAWHFXHAACDFT-FXQIFTODSA-N 0.000 description 1
- GFEDXKNBZMPEDM-KZVJFYERSA-N Ala-Met-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFEDXKNBZMPEDM-KZVJFYERSA-N 0.000 description 1
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- XEPSCVXTCUUHDT-AVGNSLFASA-N Arg-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N XEPSCVXTCUUHDT-AVGNSLFASA-N 0.000 description 1
- JUWQNWXEGDYCIE-YUMQZZPRSA-N Arg-Gln-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O JUWQNWXEGDYCIE-YUMQZZPRSA-N 0.000 description 1
- PNIGSVZJNVUVJA-BQBZGAKWSA-N Arg-Gly-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O PNIGSVZJNVUVJA-BQBZGAKWSA-N 0.000 description 1
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 1
- NVUIWHJLPSZZQC-CYDGBPFRSA-N Arg-Ile-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NVUIWHJLPSZZQC-CYDGBPFRSA-N 0.000 description 1
- YQGZIRIYGHNSQO-ZPFDUUQYSA-N Arg-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YQGZIRIYGHNSQO-ZPFDUUQYSA-N 0.000 description 1
- PZBSKYJGKNNYNK-ULQDDVLXSA-N Arg-Leu-Tyr Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O PZBSKYJGKNNYNK-ULQDDVLXSA-N 0.000 description 1
- OQPAZKMGCWPERI-GUBZILKMSA-N Arg-Ser-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OQPAZKMGCWPERI-GUBZILKMSA-N 0.000 description 1
- WCZXPVPHUMYLMS-VEVYYDQMSA-N Arg-Thr-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O WCZXPVPHUMYLMS-VEVYYDQMSA-N 0.000 description 1
- ISVACHFCVRKIDG-SRVKXCTJSA-N Arg-Val-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O ISVACHFCVRKIDG-SRVKXCTJSA-N 0.000 description 1
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 1
- IARGXWMWRFOQPG-GCJQMDKQSA-N Asn-Ala-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IARGXWMWRFOQPG-GCJQMDKQSA-N 0.000 description 1
- NNMUHYLAYUSTTN-FXQIFTODSA-N Asn-Gln-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O NNMUHYLAYUSTTN-FXQIFTODSA-N 0.000 description 1
- KWQPAXYXVMHJJR-AVGNSLFASA-N Asn-Gln-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KWQPAXYXVMHJJR-AVGNSLFASA-N 0.000 description 1
- XVAPVJNJGLWGCS-ACZMJKKPSA-N Asn-Glu-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVAPVJNJGLWGCS-ACZMJKKPSA-N 0.000 description 1
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 1
- OOXUBGLNDRGOKT-FXQIFTODSA-N Asn-Ser-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OOXUBGLNDRGOKT-FXQIFTODSA-N 0.000 description 1
- PSLSTUMPZILTAH-BYULHYEWSA-N Asp-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PSLSTUMPZILTAH-BYULHYEWSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- NDUSUIGBMZCOIL-ZKWXMUAHSA-N Cys-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N NDUSUIGBMZCOIL-ZKWXMUAHSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 241000723298 Dicentrarchus labrax Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 101150106178 FGF18 gene Proteins 0.000 description 1
- 102100028075 Fibroblast growth factor 6 Human genes 0.000 description 1
- 102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 description 1
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 1
- IOFDDSNZJDIGPB-GVXVVHGQSA-N Gln-Leu-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IOFDDSNZJDIGPB-GVXVVHGQSA-N 0.000 description 1
- UBRQJXFDVZNYJP-AVGNSLFASA-N Gln-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O UBRQJXFDVZNYJP-AVGNSLFASA-N 0.000 description 1
- VEYGCDYMOXHJLS-GVXVVHGQSA-N Gln-Val-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VEYGCDYMOXHJLS-GVXVVHGQSA-N 0.000 description 1
- WZZSKAJIHTUUSG-ACZMJKKPSA-N Glu-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O WZZSKAJIHTUUSG-ACZMJKKPSA-N 0.000 description 1
- NLKVNZUFDPWPNL-YUMQZZPRSA-N Glu-Arg-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O NLKVNZUFDPWPNL-YUMQZZPRSA-N 0.000 description 1
- NTBDVNJIWCKURJ-ACZMJKKPSA-N Glu-Asp-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NTBDVNJIWCKURJ-ACZMJKKPSA-N 0.000 description 1
- ISXJHXGYMJKXOI-GUBZILKMSA-N Glu-Cys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O ISXJHXGYMJKXOI-GUBZILKMSA-N 0.000 description 1
- ZHNHJYYFCGUZNQ-KBIXCLLPSA-N Glu-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O ZHNHJYYFCGUZNQ-KBIXCLLPSA-N 0.000 description 1
- SJJHXJDSNQJMMW-SRVKXCTJSA-N Glu-Lys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O SJJHXJDSNQJMMW-SRVKXCTJSA-N 0.000 description 1
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 1
- IDEODOAVGCMUQV-GUBZILKMSA-N Glu-Ser-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IDEODOAVGCMUQV-GUBZILKMSA-N 0.000 description 1
- FKJQNJCQTKUBCD-XPUUQOCRSA-N Gly-Ala-His Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O FKJQNJCQTKUBCD-XPUUQOCRSA-N 0.000 description 1
- UPOJUWHGMDJUQZ-IUCAKERBSA-N Gly-Arg-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UPOJUWHGMDJUQZ-IUCAKERBSA-N 0.000 description 1
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 1
- HFXJIZNEXNIZIJ-BQBZGAKWSA-N Gly-Glu-Gln Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFXJIZNEXNIZIJ-BQBZGAKWSA-N 0.000 description 1
- ZQIMMEYPEXIYBB-IUCAKERBSA-N Gly-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN ZQIMMEYPEXIYBB-IUCAKERBSA-N 0.000 description 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 1
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 1
- HAXARWKYFIIHKD-ZKWXMUAHSA-N Gly-Ile-Ser Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HAXARWKYFIIHKD-ZKWXMUAHSA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 1
- VEPBEGNDJYANCF-QWRGUYRKSA-N Gly-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN VEPBEGNDJYANCF-QWRGUYRKSA-N 0.000 description 1
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 1
- FKYQEVBRZSFAMJ-QWRGUYRKSA-N Gly-Ser-Tyr Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FKYQEVBRZSFAMJ-QWRGUYRKSA-N 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- VJJSDSNFXCWCEJ-DJFWLOJKSA-N His-Ile-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O VJJSDSNFXCWCEJ-DJFWLOJKSA-N 0.000 description 1
- JMSONHOUHFDOJH-GUBZILKMSA-N His-Ser-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 JMSONHOUHFDOJH-GUBZILKMSA-N 0.000 description 1
- CCUSLCQWVMWTIS-IXOXFDKPSA-N His-Thr-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O CCUSLCQWVMWTIS-IXOXFDKPSA-N 0.000 description 1
- 101001060265 Homo sapiens Fibroblast growth factor 6 Proteins 0.000 description 1
- 101000917134 Homo sapiens Fibroblast growth factor receptor 4 Proteins 0.000 description 1
- NZGTYCMLUGYMCV-XUXIUFHCSA-N Ile-Lys-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N NZGTYCMLUGYMCV-XUXIUFHCSA-N 0.000 description 1
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
- YBKKLDBBPFIXBQ-MBLNEYKQSA-N Ile-Thr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O)N YBKKLDBBPFIXBQ-MBLNEYKQSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- XVSJMWYYLHPDKY-DCAQKATOSA-N Leu-Asp-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O XVSJMWYYLHPDKY-DCAQKATOSA-N 0.000 description 1
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 1
- BABSVXFGKFLIGW-UWVGGRQHSA-N Leu-Gly-Arg Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N BABSVXFGKFLIGW-UWVGGRQHSA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- BJWKOATWNQJPSK-SRVKXCTJSA-N Leu-Met-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N BJWKOATWNQJPSK-SRVKXCTJSA-N 0.000 description 1
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 1
- RRVCZCNFXIFGRA-DCAQKATOSA-N Leu-Pro-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O RRVCZCNFXIFGRA-DCAQKATOSA-N 0.000 description 1
- KNKHAVVBVXKOGX-JXUBOQSCSA-N Lys-Ala-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KNKHAVVBVXKOGX-JXUBOQSCSA-N 0.000 description 1
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 1
- PBLLTSKBTAHDNA-KBPBESRZSA-N Lys-Gly-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PBLLTSKBTAHDNA-KBPBESRZSA-N 0.000 description 1
- BEGQVWUZFXLNHZ-IHPCNDPISA-N Lys-Lys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(O)=O)=CNC2=C1 BEGQVWUZFXLNHZ-IHPCNDPISA-N 0.000 description 1
- AZOFEHCPMBRNFD-BZSNNMDCSA-N Lys-Phe-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 AZOFEHCPMBRNFD-BZSNNMDCSA-N 0.000 description 1
- DRRXXZBXDMLGFC-IHRRRGAJSA-N Lys-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN DRRXXZBXDMLGFC-IHRRRGAJSA-N 0.000 description 1
- UYAKZHGIPRCGPF-CIUDSAMLSA-N Met-Glu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)N UYAKZHGIPRCGPF-CIUDSAMLSA-N 0.000 description 1
- RDLSEGZJMYGFNS-FXQIFTODSA-N Met-Ser-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RDLSEGZJMYGFNS-FXQIFTODSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000276618 Perciformes Species 0.000 description 1
- ULECEJGNDHWSKD-QEJZJMRPSA-N Phe-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 ULECEJGNDHWSKD-QEJZJMRPSA-N 0.000 description 1
- VADLTGVIOIOKGM-BZSNNMDCSA-N Phe-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CN=CN1 VADLTGVIOIOKGM-BZSNNMDCSA-N 0.000 description 1
- KNYPNEYICHHLQL-ACRUOGEOSA-N Phe-Leu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 KNYPNEYICHHLQL-ACRUOGEOSA-N 0.000 description 1
- WLYPRKLMRIYGPP-JYJNAYRXSA-N Phe-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 WLYPRKLMRIYGPP-JYJNAYRXSA-N 0.000 description 1
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 description 1
- MMPBPRXOFJNCCN-ZEWNOJEFSA-N Phe-Tyr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MMPBPRXOFJNCCN-ZEWNOJEFSA-N 0.000 description 1
- CDHURCQGUDNBMA-UBHSHLNASA-N Phe-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 CDHURCQGUDNBMA-UBHSHLNASA-N 0.000 description 1
- GAMLAXHLYGLQBJ-UFYCRDLUSA-N Phe-Val-Tyr Chemical compound N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC1=CC=C(C=C1)O)C(C)C)CC1=CC=CC=C1 GAMLAXHLYGLQBJ-UFYCRDLUSA-N 0.000 description 1
- UEHYFUCOGHWASA-HJGDQZAQSA-N Pro-Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 UEHYFUCOGHWASA-HJGDQZAQSA-N 0.000 description 1
- VYWNORHENYEQDW-YUMQZZPRSA-N Pro-Gly-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 VYWNORHENYEQDW-YUMQZZPRSA-N 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- HQTKVSCNCDLXSX-BQBZGAKWSA-N Ser-Arg-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O HQTKVSCNCDLXSX-BQBZGAKWSA-N 0.000 description 1
- HEQPKICPPDOSIN-SRVKXCTJSA-N Ser-Asp-Tyr Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HEQPKICPPDOSIN-SRVKXCTJSA-N 0.000 description 1
- HVKMTOIAYDOJPL-NRPADANISA-N Ser-Gln-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O HVKMTOIAYDOJPL-NRPADANISA-N 0.000 description 1
- BRGQQXQKPUCUJQ-KBIXCLLPSA-N Ser-Glu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BRGQQXQKPUCUJQ-KBIXCLLPSA-N 0.000 description 1
- LALNXSXEYFUUDD-GUBZILKMSA-N Ser-Glu-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LALNXSXEYFUUDD-GUBZILKMSA-N 0.000 description 1
- OHKFXGKHSJKKAL-NRPADANISA-N Ser-Glu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OHKFXGKHSJKKAL-NRPADANISA-N 0.000 description 1
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 1
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 1
- PLQWGQUNUPMNOD-KKUMJFAQSA-N Ser-Tyr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PLQWGQUNUPMNOD-KKUMJFAQSA-N 0.000 description 1
- SYCFMSYTIFXWAJ-DCAQKATOSA-N Ser-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N SYCFMSYTIFXWAJ-DCAQKATOSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- 241001417495 Serranidae Species 0.000 description 1
- SWIKDOUVROTZCW-GCJQMDKQSA-N Thr-Asn-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O SWIKDOUVROTZCW-GCJQMDKQSA-N 0.000 description 1
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 1
- FIFDDJFLNVAVMS-RHYQMDGZSA-N Thr-Leu-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O FIFDDJFLNVAVMS-RHYQMDGZSA-N 0.000 description 1
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 1
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 1
- SSSDKJMQMZTMJP-BVSLBCMMSA-N Trp-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CC=C(O)C=C1 SSSDKJMQMZTMJP-BVSLBCMMSA-N 0.000 description 1
- AKXBNSZMYAOGLS-STQMWFEESA-N Tyr-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AKXBNSZMYAOGLS-STQMWFEESA-N 0.000 description 1
- XBWKCYFGRXKWGO-SRVKXCTJSA-N Tyr-Cys-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O XBWKCYFGRXKWGO-SRVKXCTJSA-N 0.000 description 1
- QAYSODICXVZUIA-WLTAIBSBSA-N Tyr-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QAYSODICXVZUIA-WLTAIBSBSA-N 0.000 description 1
- CTDPLKMBVALCGN-JSGCOSHPSA-N Tyr-Gly-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O CTDPLKMBVALCGN-JSGCOSHPSA-N 0.000 description 1
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 1
- NKUGCYDFQKFVOJ-JYJNAYRXSA-N Tyr-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NKUGCYDFQKFVOJ-JYJNAYRXSA-N 0.000 description 1
- DWAMXBFJNZIHMC-KBPBESRZSA-N Tyr-Leu-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O DWAMXBFJNZIHMC-KBPBESRZSA-N 0.000 description 1
- VTCKHZJKWQENKX-KBPBESRZSA-N Tyr-Lys-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O VTCKHZJKWQENKX-KBPBESRZSA-N 0.000 description 1
- QGFPYRPIUXBYGR-YDHLFZDLSA-N Val-Asn-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N QGFPYRPIUXBYGR-YDHLFZDLSA-N 0.000 description 1
- SYOMXKPPFZRELL-ONGXEEELSA-N Val-Gly-Lys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N SYOMXKPPFZRELL-ONGXEEELSA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- TVGWMCTYUFBXAP-QTKMDUPCSA-N Val-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N)O TVGWMCTYUFBXAP-QTKMDUPCSA-N 0.000 description 1
- JXCOEPXCBVCTRD-JYJNAYRXSA-N Val-Tyr-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N JXCOEPXCBVCTRD-JYJNAYRXSA-N 0.000 description 1
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010078326 glycyl-glycyl-valine Proteins 0.000 description 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000001320 lysogenic effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108010025826 prolyl-leucyl-arginine Proteins 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000001057 smooth muscle myoblast Anatomy 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明提供了一种花鲈FGF6A、FGF6B以及FGF18重组蛋白及其制备方法和应用，花鲈FGF6A、FGF6B以及FGF18重组蛋白，包含：FGF6A、FGF6B以及FGF18成熟肽氨基酸序列，以及连接到FGF6A、FGF6B、FGF18成熟肽氨基酸序列的N端的标签肽段，标签肽段包含组氨基酸标签序列和促溶标签序列。本发明还提供了编码该重组蛋白的基因、表达该重组蛋白的载体和重组工程菌。本发明还进一步提供了重组蛋白的制备方法，以及该重组蛋白在花鲈育种的应用。本发明的重组蛋白可通过原核细菌大量诱导表达获取可溶性FGF6A、FGF6B、FGF18重组蛋白，且具有活性，有利于后续工业化提取和纯化。
Description
技术领域
本发明属于基因工程技术领域，具体涉及一种大肠杆菌表达系统生产可溶的、有生物活性的花鲈FGF(FGF6A、FGF6B以及FGF18)重组蛋白、制备方法及其在花鲈育种中的应用。
背景技术
花鲈(Lateolabrax maculatus)，俗称海鲈，隶属鲈形目(Perciforms)、鮨科(Serranidae)、花鲈属(Lateolabrax)，其肉质细嫩、味道鲜美、营养价值高，广受消费者喜爱。花鲈为典型的广温、广盐性鱼类，抗逆、抗病能力强，能很好的利用人工配合饲料，在池塘、工厂化、网箱等水体中均可良好生长，具有非常广阔的养殖前景。近年来，我国花鲈养殖年产量均超过15万吨，位居海水养殖鱼类产量前三位，已成为海水养殖支柱产业。然而，花鲈的遗传育种工作起步较晚，目前养殖用亲鱼来源单一且未进行科学选育，累代繁殖后种质退化现象已经显现，良种的缺乏将对花鲈产业的健康可持续发展产生严重的不利影响。急需开展花鲈遗传改良的研究工作，为优质高产的花鲈良种培育提供理论和技术支撑。
生长性状是鱼类遗传改良最有价值的经济性状之一。作为鱼类最大的组织，骨骼肌的生长对鱼类躯体的生长起到了决定性的作用。骨骼肌由多核肌纤维组成，肌纤维的增生取决于卫星细胞，卫星细胞作为动物骨骼肌中的干细胞，被激活后可以进行增殖并分化成肌纤维。因此，骨骼肌细胞的发育分化进程显著影响鱼类的生长表现。成纤维细胞生长因子(Fibroblast growth factors,FGFs)是一类重要的细胞信号蛋白，人体细胞中存在22个该家族成员，其功能主要包括参与细胞增殖、分化、迁移、凋亡等多种生物学过程。研究表明，在哺乳动物中，FGFs作为一种促分裂原素参与骨骼肌细胞的发育调控。在信号传导过程中，FGFs结合并激活跨膜的受体蛋白—成纤维细胞生长因子受体(Fibroblast growthfactor receptors,FGFRs)，进而将信号传递到细胞内发挥作用。据报道，在哺乳动物中FGF6及FGF18能与FGFR4结合，参与骨骼肌细胞增殖、分化过程。FGFs-FGFR通路调控骨骼肌细胞增殖、分化的分子机制研究仍处于探索阶段，在鱼类中的相关研究仍属空白。
发明内容
针对现有技术中的不足，本发明的目的是提供一种花鲈FGF6A、FGF6B以及FGF18重组蛋白及其制备方法和应用。
为达到上述目的，本发明的解决方案是：
一种花鲈FGF6A、FGF6B以及FGF18重组蛋白，其包括：FGF6A、FGF6B以及FGF18成熟肽氨基酸序列，以及连接到FGF6A、FGF6B以及FGF18成熟肽氨基酸序列的N端的标签肽段。
其中，标签肽段包括组氨基酸标签序列和促溶标签序列。
作为本发明的优选实施例，FGF6A、FGF6B以及FGF18成熟肽氨基酸序列分别为SEQID NO.1、SEQ ID NO.2和SEQ ID NO.3。
作为本发明的优选实施例，促溶标签序列为小泛素相关修饰蛋白(SUMO)序列。
作为本发明的优选实施例，SUMO氨基酸序列为SEQ ID NO.4。
作为本发明的优选实施例，组氨基酸标签序列为六聚组氨酸(His6)。
作为本发明的优选实施例，花鲈FGF6A、FGF6B以及FGF18重组蛋白的氨基酸序列分别为SEQ ID NO.5、SEQ ID NO.6和SEQ ID NO.7。
编码上述的花鲈FGF6A、FGF6B以及FGF18重组蛋白的基因，其包括：编码FGF6A、FGF6B以及FGF18成熟肽氨基酸的基因序列，以及连接到FGF6A、FGF6B以及FGF18成熟肽氨基酸基因序列的5'端的标签肽段的编码基因序列，标签肽段的编码基因序列包括组氨基酸标签编码基因序列和促溶标签编码基因序列。
作为本发明的优选实施例，编码FGF6A、FGF6B以及FGF18成熟肽氨基酸对应的核苷酸序列分别为SEQ ID NO.8、SEQ ID NO.9和SEQ ID NO.10。
作为本发明的优选实施例，编码FGF6A、FGF6B以及FGF18重组蛋白对应的核苷酸序列分别为SEQ ID NO.11、SEQ ID NO.12和SEQ ID NO.13。
一种用于表达上述的花鲈FGF6A、FGF6B以及FGF18重组蛋白的表达载体，其包含花鲈FGF6A、FGF6B以及FGF18重组蛋白的编码基因和骨架质粒，骨架质粒为pET-28a(+)。
一种用于表达上述的花鲈FGF6A、FGF6B以及FGF18重组蛋白的重组工程菌，其包括上述的表达载体。
作为本发明的优选实施例，重组工程菌的宿主菌选自BL21(DE3)。
一种花鲈FGF6A、FGF6B以及FGF18重组蛋白的制备方法，其包括如下步骤：
1)构建上述的FGF6A、FGF6B以及FGF18重组蛋白编码基因，然后连到到骨架质粒上构建得到FGF6A、FGF6B以及FGF18重组蛋白的表达载体；
2)将表达载体转化到宿主菌中，诱导表达FGF6A、FGF6B以及FGF18重组蛋白；
3)基于FGF6A、FGF6B以及FGF18重组蛋白中的组氨酸标签亲和层析分离得到FGF6A、FGF6B以及FGF18重组蛋白。
作为本发明的优选实施例，步骤1)中，编码FGF6A、FGF6B以及FGF18成熟肽氨基酸对应的核苷酸序列分别为SEQ ID NO.8、SEQ ID NO.9和SEQ ID NO.10。
作为本发明的优选实施例，步骤1)中，骨架质粒为pET-28a(+)。
作为本发明的优选实施例，步骤2)中，宿主菌选自BL21(DE3)。
一种上述的花鲈FGF6A、FGF6B以及FGF18重组蛋白在花鲈育种中的应用。
由于采用上述方案，本发明的有益效果是：
本发明首次构建了花鲈FGF6A、FGF6B以及FGF18的原核表达载体，并且将该载体转染BL21(DE3)大肠杆菌，得到的pET-28a(+)-SUMO-FGF-BL21(DE3)表达菌株，能大量诱导表达获取可溶的重组蛋白。通过蛋白质标签亲和纯化后，可得到重组蛋白。本发明的方法能够得到氨基酸序列与FGF6A、FGF6B以及FGF18成熟肽一致的花鲈FGF6A、FGF6B以及FGF18重组蛋白，该花鲈FGF6A、FGF6B以及FGF18重组蛋白能够用于花鲈生长相关研究。另外，本发明的重组蛋白可通过原核细菌大量诱导表达获取可溶性FGF6A、FGF6B、FGF18重组蛋白，且具有活性，有利于后续工业化提取和纯化。
附图说明
通过阅读下文优选实施方式的详细描述，各种其他的优点和益处对于本领域普通技术人员将变得清楚明了。附图仅用于示出优选实施方式的目的，而并不认为是对本发明的限制。而且在整个附图中，用相同的参考符号表示相同的部件。在附图中：
图1为花鲈FGF基因开放阅读框(ORF)克隆；其中，A、B、C分别为FGF6A、FGF6B、FGF18基因ORF核苷酸序列以及翻译的氨基酸序列，灰色区域为FGF6A、FGF6B以及FGF18成熟肽氨基酸序列。
图2为花鲈FGF6A、FGF6B以及FGF18重组蛋白基因序列及翻译的氨基酸序列；其中：深灰色区域：His6标签；中灰色区域：SUMO标签；浅灰色区域：花鲈FGF6A、FGF6B以及FGF18成熟肽。
图3为FGF6A、FGF6B以及FGF18重组蛋白表达、纯化SDS-PAGE凝胶电泳图；其中，M：蛋白分子量标准；1：IPTG诱导前细菌总蛋白；2：0.15mmol/L IPTG 20℃诱导16h后细菌总蛋白；3：诱导后细菌裂解液沉淀；4：诱导后细菌裂解液上清；5：TED-Ni亲和纯化流穿液；6-7：洗杂液；8-9：洗脱液(含目的蛋白)。
图4为花鲈FGF6A、FGF6B以及FGF18重组蛋白刺激诱导分化的骨骼肌细胞3d后细胞早期分化标记基因myog的mRNA相对表达水平；其中，A：FGF6A基因；B：FGF6B基因；C：FGF18基因。
具体实施方式
本发明提供了一种花鲈FGF6A、FGF6B以及FGF18重组蛋白及其制备方法和应用。
下面将参照附图更详细地描述本公开的示例性实施方式。虽然附图中显示了本公开的示例性实施方式，然而应当理解，可以以各种形式实现本公开而不应被这里阐述的实施方式所限制。相反，提供这些实施方式是为了能够更透彻地理解本公开，并且能够将本公开的范围完整的传达给本领域的技术人员。
实施例1：花鲈FGF6A、FGF6B以及FGF18表达载体pET-28a(+)-SUMO-FGF的构建
以花鲈肌肉cDNA为模板，使用引物FGF6A-F/R、FGF6B-F/R、FGF18-F/R(生工，上海)和试剂2×Phanta Max Master Mix(诺唯赞，南京)进行PCR扩增出花鲈FGF6A、FGF6B以及FGF18基因的开放阅读框(ORF)的DNA序列。通过TOPO连接将其连入pCE2 TA/Blunt Zero载体(诺唯赞，南京)转染DH5α大肠杆菌，氨苄固体培养基筛选单菌落，桑格测序、NCBI BLAST鉴定序列是否无误。以上述花鲈FGF6A、FGF6B以及FGF18单克隆菌液为模板，使用引物PE-FGF-F/R和2×Phanta Max Master Mix进行PCR扩增，得到带有同源臂的FGF6A、FGF6B以及FGF18成熟肽对应的双链DNA片段；同时将pET-28a(+)-SUMO载体用限制性核酸内切酶BamHI和Xho I(NEB，美国)双酶切线性化。使用FastPure Gel DNA Extraction Mini Kit(诺唯赞，南京)将PCR产物以及双酶切产物胶回收，用无缝克隆试剂盒(碧云天，上海)连接插入片段和线性载体，转染DH5α感受态大肠杆菌，氨苄固体培养基筛选单菌落，桑格测序确认无误后，使用质粒小提中量试剂盒(天根，北京)抽提质粒，即为花鲈FGF6A、FGF6B以及FGF18原核表达载体。
表1载体构建所使用的引物序列图表
注：引物小写字母示同源臂，用于同源重组连接构建原核表达载体
实施例2：花鲈FGF6A、FGF6B以及FGF18大肠杆菌表达菌株的制备
将表达载体pET-28a(+)-SUMO-FGF转染BL21(DE3)感受态大肠杆菌(昂羽，上海)，用卡那霉素抗性LB固体培养基37℃培养过夜筛选单菌落，即为花鲈FGF6A、FGF6B以及FGF18原核表达工程菌pET-28a(+)-SUMO-FGF-BL21(DE3)。挑取单菌落在10mL卡那霉素抗性LB液体培养基中37℃，220转/分培养过夜，然后按照1:100的比例接种在100mL卡那霉素抗性LB液体培养基中，37℃，220转/分培养至OD600到0.4-0.5，然后加入IPTG使其终浓度为0.15mmol/L(取出50mL菌液作为诱导前的对照)，20℃，120转/分培养12h后4000×g离心10min收集菌体，弃上清，菌体用5mL非变性裂菌缓冲液(500mmol/L NaCl，20mmol/L PB，pH为7.4)重悬，加入终浓度1mg/mL溶菌酶，冰上裂解30min，60W超声破碎15min，超5s停5s，12000×g离心10min分别收集上清和沉淀，沉淀用5mL非变性裂菌缓冲液重悬，分别取80μL样品和20μL 5×蛋白上样缓冲液混匀，金属浴95℃、10min，进行SDS-PAGE验证蛋白是否正确表达(图3中样品1-4)。
实施例3：花鲈FGF6A、FGF6B以及FGF18重组蛋白可溶表达、蛋白纯化
按照1:100的比例接种在500mL卡那霉素抗性LB液体培养基中，37℃，220转/分培养至OD600到0.4-0.5，然后加入IPTG使其终浓度为0.15mmol/L，20℃，120转/分培养12h后4000×g离心10min收集菌体，弃上清，菌体用50mL非变性裂菌缓冲液重悬，加入终浓度1mg/mL溶菌酶，冰上裂解30min，60W超声破碎15min，超5s停5s，12000×g离心10min弃沉淀，保留上清，用0.45μm或0.22μm滤膜过滤除去不溶的微颗粒，使用TED-Ni填料(爱必信，上海)进行His标签亲和纯化，得到FGF6A、FGF6B以及FGF18重组蛋白(图3中样品8-9)，可用于花鲈活体注射或者刺激离体细胞。
实施例4：FGF6A、FGF6B以及FGF18重组蛋白刺激花鲈骨骼肌细胞，q-PCR检测细胞早期分化标记基因myog的mRNA相对表达量。
采集花鲈侧线以上、第一背鳍以下的肌肉，体外培养花鲈骨骼肌细胞。待细胞长好后，用含有20％FBS、1％(青霉素、链霉素、庆大霉素)的L15培养基将细胞浓度稀释为5×105细胞/mL，然后铺在六孔板中，每个孔加入1mL细胞稀释液和1mL的L15培养基，放在25℃的培养箱中，培养过夜后，换成2mL的无FBS的L15培养基饥饿12h，然后再加入含2％马血清、1％(青霉素、链霉素、庆大霉素)的L15培养基培养基诱导细胞分化，向处理组中每孔分别加入FGF6A、FGF6B以及FGF18蛋白，终浓度为4nmol/mL，对照组加入等浓度的空载蛋白，在培养箱中培养3d，每天更换一次培养基和FGF。3d后，收集细胞，使用TRIzol试剂(诺唯赞，南京)提取细胞总RNA。使用逆转录试剂盒(诺唯赞，南京)合成cDNA。然后，使用SYBR Green试剂盒(诺唯赞，南京)对3个重复样品进行实时定量PCR，以花鲈α-tublin作为内参基因，采用2-△△CT算法估算肌细胞早期分化标记基因myog的mRNA相对表达量。结果如图4所示。
以上所述，仅为本发明较佳的具体实施方式，但本发明的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本发明揭露的技术范围内，可轻易想到的变化或替换，都应涵盖在本发明的保护范围之内。因此，本发明的保护范围应以所述权利要求的保护范围为准。
序列表
<110> 中国海洋大学
<120> 花鲈FGF6A、FGF6B以及FGF18重组蛋白及其制备方法和应用
<160> 13
<170> SIPOSequenceListing 1.0
<210> 1
<211> 171
<212> PRT
<213> 人工序列(Artficial Sequence)
<400> 1
Tyr Pro Leu Pro Ser Gly Arg Thr Asp Ala Thr Ser Leu Glu Lys Arg
1 5 10 15
Trp Glu Thr Leu Phe Ser Arg Ser Val Leu Gly Ile Ser Gly Glu Lys
20 25 30
Pro Glu Leu Asn Trp Glu Ser Asp Tyr Leu Leu Gly Ile Lys Arg Val
35 40 45
Arg Arg Leu Tyr Cys Asn Val Gly Ile Gly Phe His Leu Gln Val Leu
50 55 60
Pro Asp Gly Gly Ile Asn Gly Ala His Asn Glu Asn Gln Tyr Ser Leu
65 70 75 80
Ile Glu Ile Ser Thr Val Glu Arg Gly Val Val Ser Leu Tyr Gly Val
85 90 95
Lys Ser Glu Leu Phe Val Ala Met Asn Ser Arg Gly Arg Leu Tyr Gly
100 105 110
Thr Thr Val Phe His Asp Glu Cys Lys Phe Lys Glu Ser Leu Leu Pro
115 120 125
Asn Asn Tyr Asn Ala Tyr Glu Ser Leu Val Tyr Arg Gly Ser Tyr Ile
130 135 140
Ala Leu Ser Lys His Gly Arg Val Lys Arg Gly Asn Lys Ala Thr Thr
145 150 155 160
Ala Met Thr Val Thr His Phe Leu Pro Arg Ile
165 170
<210> 2
<211> 170
<212> PRT
<213> 人工序列(Artficial Sequence)
<400> 2
Tyr Pro Ile Pro Ser Arg Thr Asn Ala Thr Leu Met Glu Lys Lys Trp
1 5 10 15
Glu Thr Leu Phe Ser Arg Ser Tyr Leu Gly Ile Thr Gly Ser Lys Ser
20 25 30
Glu Leu Asn Trp Glu Ser Asp Tyr Leu Gln Gly Ile Lys Arg Val Arg
35 40 45
Arg Leu Tyr Cys Asn Val Gly Ile Gly Phe His Leu Gln Val Leu Pro
50 55 60
Asp Gly Arg Ile Ser Gly Ala His Ser Glu Asn Gln Tyr Ser Leu Ile
65 70 75 80
Glu Ile Ser Thr Val Asp Arg Gly Val Ile Ser Leu Phe Gly Val Arg
85 90 95
Ser Glu Leu Phe Val Ala Met Asn Ser Arg Gly Arg Leu Tyr Gly Thr
100 105 110
Arg Val Phe Val Asp Glu Cys Lys Phe Lys Glu Thr Leu Leu Pro Asn
115 120 125
Asn Tyr Asn Ala Tyr Glu Ser Phe Val Tyr Lys Gly Phe Tyr Ile Ala
130 135 140
Leu Ser Lys His Gly Arg Val Lys Arg Gly Asn Lys Ala Thr Thr Val
145 150 155 160
Met Thr Val Thr His Phe Leu Pro Arg Leu
165 170
<210> 3
<211> 169
<212> PRT
<213> 人工序列(Artficial Sequence)
<400> 3
Thr Gln Val Arg Asp Thr Met Ser Arg Arg His His Arg Val Tyr Gln
1 5 10 15
Leu Tyr Ser Arg Thr Ser Gly Lys His Val Gln Val Leu Gly Arg Arg
20 25 30
Ile Ser Ala Arg Gly Glu Asp Gly Asp Lys Tyr Ala Gln Leu Val Val
35 40 45
Glu Ala Asp Thr Phe Gly Ser Gln Val Arg Ile Arg Gly Lys Glu Thr
50 55 60
Asn Phe Tyr Leu Cys Met Asn Arg Arg Gly Lys Leu Val Gly Lys Lys
65 70 75 80
Ala Ser Asn Arg Ser Ala Asp Cys Val Phe Val Glu Lys Val Leu Glu
85 90 95
Asn His Tyr Thr Ala Leu Met Ser Ala Arg Tyr Thr Gly Trp Tyr Val
100 105 110
Gly Phe Thr Lys Arg Gly Arg Pro Arg Arg Gly Pro His Thr Leu Pro
115 120 125
Asn Gln Gln Asp Val His Phe Met Lys Arg Phe Pro Pro Gly Glu Gln
130 135 140
Pro Asp Leu Thr Thr Pro Phe Arg Phe Thr Thr Val Ser Lys Arg Gly
145 150 155 160
Lys Arg Val Arg Ala Thr Gly Pro Arg
165
<210> 4
<211> 98
<212> PRT
<213> 人工序列(Artficial Sequence)
<400> 4
Met Ser Asp Ser Glu Val Asn Gln Glu Ala Lys Pro Glu Val Lys Pro
1 5 10 15
Glu Val Lys Pro Glu Thr His Ile Asn Leu Lys Val Ser Asp Gly Ser
20 25 30
Ser Glu Ile Phe Phe Lys Ile Lys Lys Thr Thr Pro Leu Arg Arg Leu
35 40 45
Met Glu Ala Phe Ala Lys Arg Gln Gly Lys Glu Met Asp Ser Leu Arg
50 55 60
Phe Leu Tyr Asp Gly Ile Arg Ile Gln Ala Asp Gln Thr Pro Glu Asp
65 70 75 80
Leu Asp Met Glu Asp Asn Asp Ile Ile Glu Ala His Arg Glu Gln Ile
85 90 95
Gly Gly
<210> 5
<211> 292
<212> PRT
<213> 人工序列(Artficial Sequence)
<400> 5
Met Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro
1 5 10 15
Arg Gly Ser His Met Ala Ser Met Ser Asp Ser Glu Val Asn Gln Glu
20 25 30
Ala Lys Pro Glu Val Lys Pro Glu Val Lys Pro Glu Thr His Ile Asn
35 40 45
Leu Lys Val Ser Asp Gly Ser Ser Glu Ile Phe Phe Lys Ile Lys Lys
50 55 60
Thr Thr Pro Leu Arg Arg Leu Met Glu Ala Phe Ala Lys Arg Gln Gly
65 70 75 80
Lys Glu Met Asp Ser Leu Arg Phe Leu Tyr Asp Gly Ile Arg Ile Gln
85 90 95
Ala Asp Gln Thr Pro Glu Asp Leu Asp Met Glu Asp Asn Asp Ile Ile
100 105 110
Glu Ala His Arg Glu Gln Ile Gly Gly Tyr Pro Leu Pro Ser Gly Arg
115 120 125
Thr Asp Ala Thr Ser Leu Glu Lys Arg Trp Glu Thr Leu Phe Ser Arg
130 135 140
Ser Val Leu Gly Ile Ser Gly Glu Lys Pro Glu Leu Asn Trp Glu Ser
145 150 155 160
Asp Tyr Leu Leu Gly Ile Lys Arg Val Arg Arg Leu Tyr Cys Asn Val
165 170 175
Gly Ile Gly Phe His Leu Gln Val Leu Pro Asp Gly Gly Ile Asn Gly
180 185 190
Ala His Asn Glu Asn Gln Tyr Ser Leu Ile Glu Ile Ser Thr Val Glu
195 200 205
Arg Gly Val Val Ser Leu Tyr Gly Val Lys Ser Glu Leu Phe Val Ala
210 215 220
Met Asn Ser Arg Gly Arg Leu Tyr Gly Thr Thr Val Phe His Asp Glu
225 230 235 240
Cys Lys Phe Lys Glu Ser Leu Leu Pro Asn Asn Tyr Asn Ala Tyr Glu
245 250 255
Ser Leu Val Tyr Arg Gly Ser Tyr Ile Ala Leu Ser Lys His Gly Arg
260 265 270
Val Lys Arg Gly Asn Lys Ala Thr Thr Ala Met Thr Val Thr His Phe
275 280 285
Leu Pro Arg Ile
290
<210> 6
<211> 291
<212> PRT
<213> 人工序列(Artficial Sequence)
<400> 6
Met Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro
1 5 10 15
Arg Gly Ser His Met Ala Ser Met Ser Asp Ser Glu Val Asn Gln Glu
20 25 30
Ala Lys Pro Glu Val Lys Pro Glu Val Lys Pro Glu Thr His Ile Asn
35 40 45
Leu Lys Val Ser Asp Gly Ser Ser Glu Ile Phe Phe Lys Ile Lys Lys
50 55 60
Thr Thr Pro Leu Arg Arg Leu Met Glu Ala Phe Ala Lys Arg Gln Gly
65 70 75 80
Lys Glu Met Asp Ser Leu Arg Phe Leu Tyr Asp Gly Ile Arg Ile Gln
85 90 95
Ala Asp Gln Thr Pro Glu Asp Leu Asp Met Glu Asp Asn Asp Ile Ile
100 105 110
Glu Ala His Arg Glu Gln Ile Gly Gly Tyr Pro Ile Pro Ser Arg Thr
115 120 125
Asn Ala Thr Leu Met Glu Lys Lys Trp Glu Thr Leu Phe Ser Arg Ser
130 135 140
Tyr Leu Gly Ile Thr Gly Ser Lys Ser Glu Leu Asn Trp Glu Ser Asp
145 150 155 160
Tyr Leu Gln Gly Ile Lys Arg Val Arg Arg Leu Tyr Cys Asn Val Gly
165 170 175
Ile Gly Phe His Leu Gln Val Leu Pro Asp Gly Arg Ile Ser Gly Ala
180 185 190
His Ser Glu Asn Gln Tyr Ser Leu Ile Glu Ile Ser Thr Val Asp Arg
195 200 205
Gly Val Ile Ser Leu Phe Gly Val Arg Ser Glu Leu Phe Val Ala Met
210 215 220
Asn Ser Arg Gly Arg Leu Tyr Gly Thr Arg Val Phe Val Asp Glu Cys
225 230 235 240
Lys Phe Lys Glu Thr Leu Leu Pro Asn Asn Tyr Asn Ala Tyr Glu Ser
245 250 255
Phe Val Tyr Lys Gly Phe Tyr Ile Ala Leu Ser Lys His Gly Arg Val
260 265 270
Lys Arg Gly Asn Lys Ala Thr Thr Val Met Thr Val Thr His Phe Leu
275 280 285
Pro Arg Leu
290
<210> 7
<211> 300
<212> PRT
<213> 人工序列(Artficial Sequence)
<400> 7
Met Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro
1 5 10 15
Arg Gly Ser His Met Ala Ser Met Ser Asp Ser Glu Val Asn Gln Glu
20 25 30
Ala Lys Pro Glu Val Lys Pro Glu Val Lys Pro Glu Thr His Ile Asn
35 40 45
Leu Lys Val Ser Asp Gly Ser Ser Glu Ile Phe Phe Lys Ile Lys Lys
50 55 60
Thr Thr Pro Leu Arg Arg Leu Met Glu Ala Phe Ala Lys Arg Gln Gly
65 70 75 80
Lys Glu Met Asp Ser Leu Arg Phe Leu Tyr Asp Gly Ile Arg Ile Gln
85 90 95
Ala Asp Gln Thr Pro Glu Asp Leu Asp Met Glu Asp Asn Asp Ile Ile
100 105 110
Glu Ala His Arg Glu Gln Ile Gly Gly Val Asn Phe Ser Val His Val
115 120 125
Glu Asn Gln Thr Gln Val Arg Asp Thr Met Ser Arg Arg His His Arg
130 135 140
Val Tyr Gln Leu Tyr Ser Arg Thr Ser Gly Lys His Val Gln Val Leu
145 150 155 160
Gly Arg Arg Ile Ser Ala Arg Gly Glu Asp Gly Asp Lys Tyr Ala Gln
165 170 175
Leu Val Val Glu Ala Asp Thr Phe Gly Ser Gln Val Arg Ile Arg Gly
180 185 190
Lys Glu Thr Asn Phe Tyr Leu Cys Met Asn Arg Arg Gly Lys Leu Val
195 200 205
Gly Lys Lys Ala Ser Asn Arg Ser Ala Asp Cys Val Phe Val Glu Lys
210 215 220
Val Leu Glu Asn His Tyr Thr Ala Leu Met Ser Ala Arg Tyr Thr Gly
225 230 235 240
Trp Tyr Val Gly Phe Thr Lys Arg Gly Arg Pro Arg Arg Gly Pro His
245 250 255
Thr Leu Pro Asn Gln Gln Asp Val His Phe Met Lys Arg Phe Pro Pro
260 265 270
Gly Glu Gln Pro Asp Leu Thr Thr Pro Phe Arg Phe Thr Thr Val Ser
275 280 285
Lys Arg Gly Lys Arg Val Arg Ala Thr Gly Pro Arg
290 295 300
<210> 8
<211> 516
<212> DNA
<213> 人工序列(Artficial Sequence)
<400> 8
tacccgctgc cgagcggcag gaccgacgca acttcgctgg agaaacgatg ggagaccctg 60
ttctcccgct ccgtgctggg gatctccggg gagaaaccgg agctcaactg ggagagcgac 120
tatctgctgg gcatcaagag agtgcggcgg ctctactgca acgtgggcat cgggtttcac 180
ctccaggtcc tccccgacgg cgggataaac ggtgcacata atgaaaacca gtacagtcta 240
atagagatct ccacggtgga gagaggagtg gtgagcctgt atggggtgaa gagtgagctg 300
tttgtcgcaa tgaacagccg cgggaggtta tacggaacga cagtcttcca tgacgagtgc 360
aagttcaagg agagcttgct cccgaacaac tacaacgcct acgagtctct ggtttacaga 420
ggctcctaca tagcactcag caagcatggc cgcgtgaaga ggggcaacaa ggccaccact 480
gccatgactg taacgcactt cctaccccga atatga 516
<210> 9
<211> 513
<212> DNA
<213> 人工序列(Artficial Sequence)
<400> 9
tatccgattc cgagcaggac taatgcgact ttaatggaaa agaagtggga gacgctcttc 60
tcccgctcct acctgggtat aaccgggtcg aaatcggagc tgaactggga gagtgactat 120
ttgcagggca tcaaaagagt gcggcggctc tactgcaacg tgggcattgg gtttcacctg 180
caggtgctcc cggatggcag gataagcggt gcacacagtg agaaccaata cagtctaata 240
gaaatctcca ccgtggaccg aggagtgatc agcctgttcg gggtgaggag cgagctgttt 300
gtcgcaatga acagcagggg aaggttatac ggaacgagag tcttcgtgga tgagtgcaag 360
ttcaaggaga ctttgctgcc caacaattac aacgcctacg agtcttttgt ttacaagggc 420
ttctatattg ccctcagcaa gcatggccgc gtaaagagag gcaacaaggc caccaccgtc 480
atgactgtca cacatttcct cccacgacta tga 513
<210> 10
<211> 540
<212> DNA
<213> 人工序列(Artficial Sequence)
<400> 10
gtcaacttca gcgtgcatgt ggagaaccag acgcaggtgc gagacaccat gagtcggcga 60
caccaccggg tctaccagct ctacagccgc accagtggca aacacgtcca ggtgctggga 120
cgcagaataa gcgctcgagg agaagatgga gacaaatatg cccagctcgt agtggaggcc 180
gatacctttg gtagccaggt gagaatccgg ggcaaagaaa ccaatttcta cctgtgcatg 240
aaccgccgcg gaaagctggt tggaaagaag gccagtaatc gaagcgccga ctgcgtcttt 300
gtggaaaagg ttctggaaaa ccactacacg gctctgatgt cggcgcgcta cacaggatgg 360
tacgtgggct tcaccaagag aggccgccct cgccgtggcc cccacacgct ccccaaccag 420
caggacgtac acttcatgaa gcgcttcccg cccggggagc agcccgacct caccacgccc 480
ttccgcttca ccaccgtcag caagcggggc aagagggtgc gcgctactgg gccccgctag 540
<210> 11
<211> 879
<212> DNA
<213> 人工序列(Artficial Sequence)
<400> 11
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggctagca tgtcggactc agaagtcaat caagaagcta agccagaggt caagccagaa 120
gtcaagcctg agactcacat caatttaaag gtgtccgatg gatcttcaga gatcttcttc 180
aagatcaaaa agaccactcc tttaagaagg ctgatggaag cgttcgctaa aagacagggt 240
aaggaaatgg actccttaag attcttgtac gacggtatta gaattcaagc tgatcagacc 300
cctgaagatt tggacatgga ggataacgat attattgagg ctcacagaga acagattggt 360
ggatacccgc tgccgagcgg caggaccgac gcaacttcgc tggagaaacg atgggagacc 420
ctgttctccc gctccgtgct ggggatctcc ggggagaaac cggagctcaa ctgggagagc 480
gactatctgc tgggcatcaa gagagtgcgg cggctctact gcaacgtggg catcgggttt 540
cacctccagg tcctccccga cggcgggata aacggtgcac ataatgaaaa ccagtacagt 600
ctaatagaga tctccacggt ggagagagga gtggtgagcc tgtatggggt gaagagtgag 660
ctgtttgtcg caatgaacag ccgcgggagg ttatacggaa cgacagtctt ccatgacgag 720
tgcaagttca aggagagctt gctcccgaac aactacaacg cctacgagtc tctggtttac 780
agaggctcct acatagcact cagcaagcat ggccgcgtga agaggggcaa caaggccacc 840
actgccatga ctgtaacgca cttcctaccc cgaatataa 879
<210> 12
<211> 876
<212> DNA
<213> 人工序列(Artficial Sequence)
<400> 12
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggctagca tgtcggactc agaagtcaat caagaagcta agccagaggt caagccagaa 120
gtcaagcctg agactcacat caatttaaag gtgtccgatg gatcttcaga gatcttcttc 180
aagatcaaaa agaccactcc tttaagaagg ctgatggaag cgttcgctaa aagacagggt 240
aaggaaatgg actccttaag attcttgtac gacggtatta gaattcaagc tgatcagacc 300
cctgaagatt tggacatgga ggataacgat attattgagg ctcacagaga acagattggt 360
ggatatccga ttccgagcag gactaatgcg actttaatgg aaaagaagtg ggagacgctc 420
ttctcccgct cctacctggg tataaccggg tcgaaatcgg agctgaactg ggagagtgac 480
tatttgcagg gcatcaaaag agtgcggcgg ctctactgca acgtgggcat tgggtttcac 540
ctgcaggtgc tcccggatgg caggataagc ggtgcacaca gtgagaacca atacagtcta 600
atagaaatct ccaccgtgga ccgaggagtg atcagcctgt tcggggtgag gagcgagctg 660
tttgtcgcaa tgaacagcag gggaaggtta tacggaacga gagtcttcgt ggatgagtgc 720
aagttcaagg agactttgct gcccaacaat tacaacgcct acgagtcttt tgtttacaag 780
ggcttctata ttgccctcag caagcatggc cgcgtaaaga gaggcaacaa ggccaccacc 840
gtcatgactg tcacacattt cctcccacga ctataa 876
<210> 13
<211> 903
<212> DNA
<213> 人工序列(Artficial Sequence)
<400> 13
atgggcagca gccatcatca tcatcatcac agcagcggcc tggtgccgcg cggcagccat 60
atggctagca tgtcggactc agaagtcaat caagaagcta agccagaggt caagccagaa 120
gtcaagcctg agactcacat caatttaaag gtgtccgatg gatcttcaga gatcttcttc 180
aagatcaaaa agaccactcc tttaagaagg ctgatggaag cgttcgctaa aagacagggt 240
aaggaaatgg actccttaag attcttgtac gacggtatta gaattcaagc tgatcagacc 300
cctgaagatt tggacatgga ggataacgat attattgagg ctcacagaga acagattggt 360
ggagtcaact tcagcgtgca tgtggagaac cagacgcagg tgcgagacac catgagtcgg 420
cgacaccacc gggtctacca gctctacagc cgcaccagtg gcaaacacgt ccaggtgctg 480
ggacgcagaa taagcgctcg aggagaagat ggagacaaat atgcccagct cgtagtggag 540
gccgatacct ttggtagcca ggtgagaatc cggggcaaag aaaccaattt ctacctgtgc 600
atgaaccgcc gcggaaagct ggttggaaag aaggccagta atcgaagcgc cgactgcgtc 660
tttgtggaaa aggttctgga aaaccactac acggctctga tgtcggcgcg ctacacagga 720
tggtacgtgg gcttcaccaa gagaggccgc cctcgccgtg gcccccacac gctccccaac 780
cagcaggacg tacacttcat gaagcgcttc ccgcccgggg agcagcccga cctcaccacg 840
cccttccgct tcaccaccgt cagcaagcgg ggcaagaggg tgcgcgctac tgggccccgc 900
taa 903
Claims (12)
1.一种花鲈FGF6A、FGF6B以及FGF18重组蛋白，其特征在于：包括：FGF6A、FGF6B以及FGF18成熟肽氨基酸序列，以及连接到所述FGF6A、FGF6B以及FGF18成熟肽氨基酸序列的N端的标签肽段；
所述标签肽段包括六聚组氨酸标签和促溶标签小泛素相关修饰蛋白（SUMO）；
所述FGF6A、FGF6B以及FGF18成熟肽氨基酸序列分别为SEQ ID NO.1、SEQ ID NO.2和SEQ ID NO.3；
所述小泛素相关修饰蛋白（SUMO）的氨基酸序列为SEQ ID NO.4。
2.根据权利要求1所述的花鲈FGF6A、FGF6B以及FGF18重组蛋白，其特征在于：所述花鲈FGF6A、FGF6B以及FGF18重组蛋白的氨基酸序列分别为SEQ ID NO.5、SEQ ID NO.6和SEQ IDNO.7。
3.编码如权利要求1或2所述的花鲈FGF6A、FGF6B以及FGF18重组蛋白的基因，其特征在于：包括：编码FGF6A、FGF6B以及FGF18成熟肽氨基酸的基因序列，以及连接到所述FGF6A、FGF6B以及FGF18成熟肽氨基酸基因序列的5'端的标签肽段的编码基因序列，所述标签肽段的编码基因序列包括组氨基酸标签编码基因序列和促溶标签编码基因序列。
4.根据权利要求3所述的基因，其特征在于：所述编码FGF6A、FGF6B以及FGF18成熟肽氨基酸对应的核苷酸序列分别为SEQ ID NO.8、SEQ ID NO.9和SEQ ID NO.10。
5.根据权利要求3所述的基因，其特征在于：所述编码FGF6A、FGF6B以及FGF18重组蛋白对应的核苷酸序列分别为SEQ ID NO.11、SEQ ID NO.12和SEQ ID NO.13。
6.一种用于表达如权利要求1或2所述的花鲈FGF6A、FGF6B以及FGF18重组蛋白的表达载体，其特征在于：包含如权利要求5所述的花鲈FGF6A、FGF6B以及FGF18重组蛋白的编码基因和骨架质粒，所述骨架质粒为pET-28a（+）。
7.一种用于表达如权利要求1或2所述的花鲈FGF6A、FGF6B以及FGF18重组蛋白的重组工程菌，其特征在于：包括如权利要求6所述的表达载体。
8.根据权利要求7所述的重组工程菌，其特征在于：所述重组工程菌的宿主菌选自BL21（DE3）。
9.一种花鲈FGF6A、FGF6B以及FGF18重组蛋白的制备方法，其特征在于：其包括如下步骤：
1）构建如权利要求5所述的FGF6A、FGF6B以及FGF18重组蛋白编码基因，然后连到到骨架质粒上构建得到FGF6A、FGF6B以及FGF18重组蛋白的表达载体；
2）将所述表达载体转化到宿主菌中，诱导表达FGF6A、FGF6B以及FGF18重组蛋白；
3）基于所述FGF6A、FGF6B以及FGF18重组蛋白中的组氨酸标签亲和层析分离得到FGF6A、FGF6B以及FGF18重组蛋白。
10.根据权利要求9所述的制备方法，其特征在于：步骤1）中，所述编码FGF6A、FGF6B以及FGF18成熟肽氨基酸对应的核苷酸序列分别为SEQ ID NO.8、SEQ ID NO.9和SEQ IDNO.10。
11.根据权利要求9所述的制备方法，其特征在于：步骤1）中，所述骨架质粒为pET-28a（+）。
12.根据权利要求9所述的制备方法，其特征在于：步骤2）中，所述宿主菌选自BL21（DE3）。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111505223.XA CN114181321B (zh) | 2021-12-10 | 2021-12-10 | 花鲈fgf6a、fgf6b以及fgf18重组蛋白及其制备方法和应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111505223.XA CN114181321B (zh) | 2021-12-10 | 2021-12-10 | 花鲈fgf6a、fgf6b以及fgf18重组蛋白及其制备方法和应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114181321A CN114181321A (zh) | 2022-03-15 |
| CN114181321B true CN114181321B (zh) | 2023-04-11 |
Family
ID=80604295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111505223.XA Active CN114181321B (zh) | 2021-12-10 | 2021-12-10 | 花鲈fgf6a、fgf6b以及fgf18重组蛋白及其制备方法和应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114181321B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115177718B (zh) * | 2022-05-25 | 2023-02-17 | 中国水产科学研究院南海水产研究所 | 花鲈干扰素IFN-γ及其受体抗病毒组合物和应用 |
| CN114958806A (zh) * | 2022-06-14 | 2022-08-30 | 中国水产科学研究院淡水渔业研究中心 | 一种鲤lpl1重组蛋白及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1084958A (ja) * | 1996-09-17 | 1998-04-07 | Pola Chem Ind Inc | 抗繊維芽細胞増殖因子６モノクローナル抗体 |
| US7858341B2 (en) * | 2004-12-10 | 2010-12-28 | Zymogenetics, Inc. | FGF18 production in prokaryotic hosts |
| CN101144093B (zh) * | 2006-09-13 | 2011-06-15 | 广州暨南大学医药生物技术研究开发中心 | 可溶性表达人ⅰ型金属硫蛋白的重组表达载体和方法 |
| CN105200085A (zh) * | 2015-10-23 | 2015-12-30 | 温州医科大学 | 重组人成纤维细胞生长因子-18的生产方法及其用途 |
| CN112979781B (zh) * | 2021-03-18 | 2022-05-17 | 中国海洋大学 | 一种许氏平鲉IL-1β重组蛋白及其制备方法和应用 |
-
2021
- 2021-12-10 CN CN202111505223.XA patent/CN114181321B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN114181321A (zh) | 2022-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3660045B1 (en) | Polypeptide, process for the production thereof and use thereof | |
| CN114181321B (zh) | 花鲈fgf6a、fgf6b以及fgf18重组蛋白及其制备方法和应用 | |
| CN114805551B (zh) | 一种重组iii型胶原蛋白及其制备方法 | |
| CN105296454B (zh) | 一种褐藻胶裂解酶基因algp及其制备方法与表达 | |
| CN114853881A (zh) | 一种重组人源融合胶原蛋白及其高效羟基化方法与应用 | |
| CN111004317B (zh) | 一种犬重组干扰素α7及其制备方法与应用 | |
| CN113087804B (zh) | 一种二价植物免疫融合蛋白及其生产方法和应用 | |
| KR101026526B1 (ko) | 대장균에서 외래단백질을 분비 생산하는 방법 | |
| CN117466990A (zh) | 一种重组人源xvii型胶原蛋白及其制备方法与应用 | |
| CN111499759B (zh) | 一种具有细胞穿膜性的锌指蛋白-乳铁蛋白融合蛋白质及其制备与应用 | |
| CN112239760B (zh) | 高效表达重组hGH的重组工程菌及构建方法和应用 | |
| CN113354745B (zh) | 一种组合物及规模化生产成纤维细胞生长因子的方法 | |
| CN113136349B (zh) | 一种高效表达不同来源肌红蛋白/血红蛋白毕赤酵母重组菌株的构建 | |
| CN107937408B (zh) | 斜带石斑鱼insulin基因、编码蛋白及其应用 | |
| KR20150117645A (ko) | 쌀 종자로부터 재조합 인간 염기성 섬유아세포성장인자를 생성하는 방법 | |
| CN117756926A (zh) | 一种重组ⅩⅦ型胶原蛋白Pro.C17及其制备方法和应用 | |
| CN114262368B (zh) | 一种重组Scl2类胶原蛋白及其可变速水凝胶的制备方法 | |
| CN113045670A (zh) | 一种可溶性鸡α干扰素融合蛋白及其生产方法与应用 | |
| CN1366551A (zh) | 分泌人粒细胞集落刺激因子(g－csf)的大肠杆菌菌株 | |
| CN110305887A (zh) | 抗真菌肽Drosomycin、制备方法及其应用 | |
| CN113249288B9 (zh) | 一种表达glp-1类似物的重组菌及其应用 | |
| CN111269916B (zh) | 一种适合大肠杆菌表达的人骨形成蛋白2编码基因 | |
| CN100370027C (zh) | 硬粒小麦高分子量谷蛋白By8基因的用途 | |
| KR102346499B1 (ko) | 페리틴 단백질 대량생산을 위한 재조합 벡터 및 이를 이용한 페리틴 단백질의 대량생산방법 | |
| CN109750021A (zh) | 一种扇贝类胡萝卜素氧化裂解酶基因及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |